Fondazione Don Carlo Gnocchi, IRCCS Santa Maria Nascente, O.U. de Neurología de Rehabilitación
Welcome,         Profile    Billing    Logout  
 4 Trials 
1 Trials

   Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Navarro, Jorge
HIPRA-HH-2, NCT05142553 / 2021-005226-26: Immunogenicity and Safety of a Booster Vaccination With a Recombinant Protein RBD Candidate Vaccine Against SARS-CoV-2 in Healthy Adults Volunteers Fully Vaccinated Followed by an Extension Period to Study a Fourth Dose Administration.

Completed
2
887
Europe
COVID-19 Vaccine HIPRA, Cominarty (Pfizer-BioNtech)
Hipra Scientific, S.L.U, Laboratorios Hipra, S.A.
COVID-19, SARS-CoV-2 Acute Respiratory Disease
05/23
05/23
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Navarro, Jorge
HIPRA-HH-2, NCT05142553 / 2021-005226-26: Immunogenicity and Safety of a Booster Vaccination With a Recombinant Protein RBD Candidate Vaccine Against SARS-CoV-2 in Healthy Adults Volunteers Fully Vaccinated Followed by an Extension Period to Study a Fourth Dose Administration.

Completed
2
887
Europe
COVID-19 Vaccine HIPRA, Cominarty (Pfizer-BioNtech)
Hipra Scientific, S.L.U, Laboratorios Hipra, S.A.
COVID-19, SARS-CoV-2 Acute Respiratory Disease
05/23
05/23

Download Options